X
Otsuka has high hopes for its ‘drug creation engine’ acquisition
https://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/
nephrology
EU approves AZ’s potential blockbuster hyperkalaemia drug
After manufacturing issues, AstraZeneca hopes for FDA nod soon.
AZ signs kidney drug deal with Ionis for up to $330m
Deal is result of six-year collaboration with AZ
Alexion drug fails in kidney transplant trial
Soliris fails when used to treat post-transplant complications.
GSK begins phase 3 trials of kidney drug
Daprodustat is potential treatment for anaemia with CKD.
Father petitions NHS to fund kidney drug for son
But NHS refuses £340,000 a year treatment.
